New survey: U.S. biotechs warn tariffs could impede access to cures, stifle innovation

WASHINGTON (March 26, 2025) — Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical supply chain. According to the findings, nearly 90% of U.S. biotech companies rely on imported components for at least half of their FDA-approved products — making the supply of medicines for US patients and families especially vulnerable to proposed tariffs on the European Union, China, and Canada. 

Continue reading

Bayh-Dole Coalition Urges President Trump to Reverse Agency Violations of the Bayh-Dole Act

WASHINGTON, D.C. (March 14, 2025) — Today, the Bayh-Dole Coalition sent a letter to President Trump calling attention to a series of actions by federal agencies that violate the Bayh-Dole Act and the recent Executive Order: Ensuring Lawful Governance and Implementing the President’s “Department Of Government Efficiency” Deregulatory Initiative.Continue reading

XLR8 PBC Announces Inaugural Cohort

Phoenix, AZ – March 14, 2025 – Phoenix Bioscience Core (PBC) is proud to announce the first cohort of XLR8 PBC, a program designed to support scale-ready health tech startups with access to top industry leaders, mentorship, and strategic resources. The selected companies represent cutting-edge advancements in medical technology, addressing critical gaps in patient care, joint health, chronic pain treatment, and remote monitoring.Continue reading